1 Total Intravenous Anesthesia (TIVA) Market Overview 1.1 Product Overview and Scope of Total Intravenous Anesthesia (TIVA) 1.2 Total Intravenous Anesthesia (TIVA) Segment by Type 1.2.1 Global Total Intravenous Anesthesia (TIVA) Sales Growth Rate Comparison by Type (2021-2027) 1.2.2 Propofol 1.2.3 Etomidate 1.2.4 Midazolam 1.2.5 Barbiturates 1.2.6 Others 1.3 Total Intravenous Anesthesia (TIVA) Segment by Application 1.3.1 Global Total Intravenous Anesthesia (TIVA) Sales Comparison by Application: (2021-2027) 1.3.2 Predominantly Emergency 1.3.3 Orthopedic 1.3.4 Cosmetic Surgeries 1.3.5 Others 1.4 Global Total Intravenous Anesthesia (TIVA) Market Size Estimates and Forecasts 1.4.1 Global Total Intravenous Anesthesia (TIVA) Revenue 2016-2027 1.4.2 Global Total Intravenous Anesthesia (TIVA) Sales 2016-2027 1.4.3 Total Intravenous Anesthesia (TIVA) Market Size by Region: 2016 Versus 2021 Versus 2027 2 Total Intravenous Anesthesia (TIVA) Market Competition by Manufacturers 2.1 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Manufacturers (2016-2021) 2.2 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Manufacturers (2016-2021) 2.3 Global Total Intravenous Anesthesia (TIVA) Average Price by Manufacturers (2016-2021) 2.4 Manufacturers Total Intravenous Anesthesia (TIVA) Manufacturing Sites, Area Served, Product Type 2.5 Total Intravenous Anesthesia (TIVA) Market Competitive Situation and Trends 2.5.1 Total Intravenous Anesthesia (TIVA) Market Concentration Rate 2.5.2 The Global Top 5 and Top 10 Largest Total Intravenous Anesthesia (TIVA) Players Market Share by Revenue 2.5.3 Global Total Intravenous Anesthesia (TIVA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 3 Total Intravenous Anesthesia (TIVA) Retrospective Market Scenario by Region 3.1 Global Total Intravenous Anesthesia (TIVA) Retrospective Market Scenario in Sales by Region: 2016-2021 3.2 Global Total Intravenous Anesthesia (TIVA) Retrospective Market Scenario in Revenue by Region: 2016-2021 3.3 North America Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country 3.3.1 North America Total Intravenous Anesthesia (TIVA) Sales by Country 3.3.2 North America Total Intravenous Anesthesia (TIVA) Revenue by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country 3.4.1 Europe Total Intravenous Anesthesia (TIVA) Sales by Country 3.4.2 Europe Total Intravenous Anesthesia (TIVA) Revenue by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Region 3.5.1 Asia Pacific Total Intravenous Anesthesia (TIVA) Sales by Region 3.5.2 Asia Pacific Total Intravenous Anesthesia (TIVA) Revenue by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country 3.6.1 Latin America Total Intravenous Anesthesia (TIVA) Sales by Country 3.6.2 Latin America Total Intravenous Anesthesia (TIVA) Revenue by Country 3.6.3 Mexico 3.6.4 Brazil 3.6.5 Argentina 3.7 Middle East and Africa Total Intravenous Anesthesia (TIVA) Market Facts & Figures by Country 3.7.1 Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales by Country 3.7.2 Middle East and Africa Total Intravenous Anesthesia (TIVA) Revenue by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Total Intravenous Anesthesia (TIVA) Historic Market Analysis by Type 4.1 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2016-2021) 4.2 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Type (2016-2021) 4.3 Global Total Intravenous Anesthesia (TIVA) Price by Type (2016-2021) 5 Global Total Intravenous Anesthesia (TIVA) Historic Market Analysis by Application 5.1 Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2016-2021) 5.2 Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Application (2016-2021) 5.3 Global Total Intravenous Anesthesia (TIVA) Price by Application (2016-2021) 6 Key Companies Profiled 6.1 B. Braun Medical 6.1.1 B. Braun Medical Corporation Information 6.1.2 B. Braun Medical Description and Business Overview 6.1.3 B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021) 6.1.4 B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Portfolio 6.1.5 B. Braun Medical Recent Developments/Updates 6.2 Astrazeneca 6.2.1 Astrazeneca Corporation Information 6.2.2 Astrazeneca Description and Business Overview 6.2.3 Astrazeneca Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021) 6.2.4 Astrazeneca Total Intravenous Anesthesia (TIVA) Product Portfolio 6.2.5 Astrazeneca Recent Developments/Updates 6.3 Fresenius-Kabi 6.3.1 Fresenius-Kabi Corporation Information 6.3.2 Fresenius-Kabi Description and Business Overview 6.3.3 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021) 6.3.4 Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Portfolio 6.3.5 Fresenius-Kabi Recent Developments/Updates 6.4 AbbVie 6.4.1 AbbVie Corporation Information 6.4.2 AbbVie Description and Business Overview 6.4.3 AbbVie Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021) 6.4.4 AbbVie Total Intravenous Anesthesia (TIVA) Product Portfolio 6.4.5 AbbVie Recent Developments/Updates 6.5 Baxter Healthcare 6.5.1 Baxter Healthcare Corporation Information 6.5.2 Baxter Healthcare Description and Business Overview 6.5.3 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021) 6.5.4 Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Portfolio 6.5.5 Baxter Healthcare Recent Developments/Updates 6.6 Maruishi 6.6.1 Maruishi Corporation Information 6.6.2 Maruishi Description and Business Overview 6.6.3 Maruishi Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021) 6.6.4 Maruishi Total Intravenous Anesthesia (TIVA) Product Portfolio 6.6.5 Maruishi Recent Developments/Updates 6.7 Piramal 6.6.1 Piramal Corporation Information 6.6.2 Piramal Description and Business Overview 6.6.3 Piramal Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021) 6.4.4 Piramal Total Intravenous Anesthesia (TIVA) Product Portfolio 6.7.5 Piramal Recent Developments/Updates 6.8 Hikma Pharmaceuticals 6.8.1 Hikma Pharmaceuticals Corporation Information 6.8.2 Hikma Pharmaceuticals Description and Business Overview 6.8.3 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021) 6.8.4 Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Portfolio 6.8.5 Hikma Pharmaceuticals Recent Developments/Updates 6.9 Mylan 6.9.1 Mylan Corporation Information 6.9.2 Mylan Description and Business Overview 6.9.3 Mylan Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021) 6.9.4 Mylan Total Intravenous Anesthesia (TIVA) Product Portfolio 6.9.5 Mylan Recent Developments/Updates 6.10 Nhwa 6.10.1 Nhwa Corporation Information 6.10.2 Nhwa Description and Business Overview 6.10.3 Nhwa Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021) 6.10.4 Nhwa Total Intravenous Anesthesia (TIVA) Product Portfolio 6.10.5 Nhwa Recent Developments/Updates 6.11 Hengrui 6.11.1 Hengrui Corporation Information 6.11.2 Hengrui Total Intravenous Anesthesia (TIVA) Description and Business Overview 6.11.3 Hengrui Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021) 6.11.4 Hengrui Total Intravenous Anesthesia (TIVA) Product Portfolio 6.11.5 Hengrui Recent Developments/Updates 6.12 Lunan 6.12.1 Lunan Corporation Information 6.12.2 Lunan Total Intravenous Anesthesia (TIVA) Description and Business Overview 6.12.3 Lunan Total Intravenous Anesthesia (TIVA) Sales, Revenue and Gross Margin (2016-2021) 6.12.4 Lunan Total Intravenous Anesthesia (TIVA) Product Portfolio 6.12.5 Lunan Recent Developments/Updates 7 Total Intravenous Anesthesia (TIVA) Manufacturing Cost Analysis 7.1 Total Intravenous Anesthesia (TIVA) Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Total Intravenous Anesthesia (TIVA) 7.4 Total Intravenous Anesthesia (TIVA) Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Total Intravenous Anesthesia (TIVA) Distributors List 8.3 Total Intravenous Anesthesia (TIVA) Customers 9 Total Intravenous Anesthesia (TIVA) Market Dynamics 9.1 Total Intravenous Anesthesia (TIVA) Industry Trends 9.2 Total Intravenous Anesthesia (TIVA) Growth Drivers 9.3 Total Intravenous Anesthesia (TIVA) Market Challenges 9.4 Total Intravenous Anesthesia (TIVA) Market Restraints 10 Global Market Forecast 10.1 Total Intravenous Anesthesia (TIVA) Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Total Intravenous Anesthesia (TIVA) by Type (2022-2027) 10.1.2 Global Forecasted Revenue of Total Intravenous Anesthesia (TIVA) by Type (2022-2027) 10.2 Total Intravenous Anesthesia (TIVA) Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Total Intravenous Anesthesia (TIVA) by Application (2022-2027) 10.2.2 Global Forecasted Revenue of Total Intravenous Anesthesia (TIVA) by Application (2022-2027) 10.3 Total Intravenous Anesthesia (TIVA) Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Total Intravenous Anesthesia (TIVA) by Region (2022-2027) 10.3.2 Global Forecasted Revenue of Total Intravenous Anesthesia (TIVA) by Region (2022-2027) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) Growth Rate Comparison by Type (2021-2027) Table 2. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) Comparison by Application (2021-2027) Table 3. Global Total Intravenous Anesthesia (TIVA) Market Size by Region (US$ Million) (2016 VS 2021 VS 2027) Table 4. Key Manufacturers Total Intravenous Anesthesia (TIVA) Covered in This Study Table 5. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) of Key Manufacturers (2016-2021) Table 6. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Manufacturers (2016-2021) Table 7. Global Total Intravenous Anesthesia (TIVA) Revenue (US$ Million) by Manufacturers (2016-2021) Table 8. Global Total Intravenous Anesthesia (TIVA) Revenue Share by Manufacturers (2016-2021) Table 9. Global Market Total Intravenous Anesthesia (TIVA) Average Price (US$/Unit) of Key Manufacturers (2016-2021) Table 10. Manufacturers Total Intravenous Anesthesia (TIVA) Manufacturing Sites and Area Served Table 11. Manufacturers Total Intravenous Anesthesia (TIVA) Product Type Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Total Intravenous Anesthesia (TIVA) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Total Intravenous Anesthesia (TIVA) as of 2020) Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Global Total Intravenous Anesthesia (TIVA) Sales by Region (2016-2021) & (K Units) Table 16. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2016-2021) Table 17. Global Total Intravenous Anesthesia (TIVA) Revenue by Region (2016-2021) & (US$ Million) Table 18. North America Total Intravenous Anesthesia (TIVA) Sales by Country (2016-2021) & (K Units) Table 19. North America Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2016-2021) Table 20. North America Total Intravenous Anesthesia (TIVA) Revenue by Country (2016-2021) & (US$ Million) Table 21. North America Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2016-2021) Table 22. Europe Total Intravenous Anesthesia (TIVA) Sales by Country (2016-2021) & (K Units) Table 23. Europe Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2016-2021) Table 24. Europe Total Intravenous Anesthesia (TIVA) Revenue by Country (2016-2021) & (US$ Million) Table 25. Europe Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2016-2021) Table 26. Asia Pacific Total Intravenous Anesthesia (TIVA) Sales by Region (2016-2021) & (K Units) Table 27. Asia Pacific Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2016-2021) Table 28. Asia Pacific Total Intravenous Anesthesia (TIVA) Revenue by Region (2016-2021) & (US$ Million) Table 29. Asia Pacific Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2016-2021) Table 30. Latin America Total Intravenous Anesthesia (TIVA) Sales by Country (2016-2021) & (K Units) Table 31. Latin America Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2016-2021) Table 32. Latin America Total Intravenous Anesthesia (TIVA) Revenue by Country (2016-2021) & (US$ Million) Table 33. Latin America Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2016-2021) Table 34. Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales by Country (2016-2021) & (K Units) Table 35. Middle East and Africa Total Intravenous Anesthesia (TIVA) Sales Market Share by Country (2016-2021) Table 36. Middle East and Africa Total Intravenous Anesthesia (TIVA) Revenue by Country (2016-2021) & (US$ Million) Table 37. Middle East and Africa Total Intravenous Anesthesia (TIVA) Revenue Market Share by Country (2016-2021) Table 38. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) by Type (2016-2021) Table 39. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Type (2016-2021) Table 40. Global Total Intravenous Anesthesia (TIVA) Revenue (Million US$) by Type (2016-2021) Table 41. Global Total Intravenous Anesthesia (TIVA) Revenue Share by Type (2016-2021) Table 42. Global Total Intravenous Anesthesia (TIVA) Price (US$/Unit) by Type (2016-2021) Table 43. Global Total Intravenous Anesthesia (TIVA) Sales (K Units) by Application (2016-2021) Table 44. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Application (2016-2021) Table 45. Global Total Intravenous Anesthesia (TIVA) Revenue (Million US$) by Application (2016-2021) Table 46. Global Total Intravenous Anesthesia (TIVA) Revenue Share by Application (2016-2021) Table 47. Global Total Intravenous Anesthesia (TIVA) Price (US$/Unit) by Application (2016-2021) Table 48. B. Braun Medical Corporation Information Table 49. B. Braun Medical Description and Business Overview Table 50. B. Braun Medical Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 51. B. Braun Medical Total Intravenous Anesthesia (TIVA) Product Table 52. B. Braun Medical Recent Developments/Updates Table 53. Astrazeneca Corporation Information Table 54. Astrazeneca Description and Business Overview Table 55. Astrazeneca Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 56. Astrazeneca Total Intravenous Anesthesia (TIVA) Product Table 57. Astrazeneca Recent Developments/Updates Table 58. Fresenius-Kabi Corporation Information Table 59. Fresenius-Kabi Description and Business Overview Table 60. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 61. Fresenius-Kabi Total Intravenous Anesthesia (TIVA) Product Table 62. Fresenius-Kabi Recent Developments/Updates Table 63. AbbVie Corporation Information Table 64. AbbVie Description and Business Overview Table 65. AbbVie Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 66. AbbVie Total Intravenous Anesthesia (TIVA) Product Table 67. AbbVie Recent Developments/Updates Table 68. Baxter Healthcare Corporation Information Table 69. Baxter Healthcare Description and Business Overview Table 70. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 71. Baxter Healthcare Total Intravenous Anesthesia (TIVA) Product Table 72. Baxter Healthcare Recent Developments/Updates Table 73. Maruishi Corporation Information Table 74. Maruishi Description and Business Overview Table 75. Maruishi Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 76. Maruishi Total Intravenous Anesthesia (TIVA) Product Table 77. Maruishi Recent Developments/Updates Table 78. Piramal Corporation Information Table 79. Piramal Description and Business Overview Table 80. Piramal Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 81. Piramal Total Intravenous Anesthesia (TIVA) Product Table 82. Piramal Recent Developments/Updates Table 83. Hikma Pharmaceuticals Corporation Information Table 84. Hikma Pharmaceuticals Description and Business Overview Table 85. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 86. Hikma Pharmaceuticals Total Intravenous Anesthesia (TIVA) Product Table 87. Hikma Pharmaceuticals Recent Developments/Updates Table 88. Mylan Corporation Information Table 89. Mylan Description and Business Overview Table 90. Mylan Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 91. Mylan Total Intravenous Anesthesia (TIVA) Product Table 92. Mylan Recent Developments/Updates Table 93. Nhwa Corporation Information Table 94. Nhwa Description and Business Overview Table 95. Nhwa Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 96. Nhwa Total Intravenous Anesthesia (TIVA) Product Table 97. Nhwa Recent Developments/Updates Table 98. Hengrui Corporation Information Table 99. Hengrui Description and Business Overview Table 100. Hengrui Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 101. Hengrui Total Intravenous Anesthesia (TIVA) Product Table 102. Hengrui Recent Developments/Updates Table 103. Lunan Corporation Information Table 104. Lunan Description and Business Overview Table 105. Lunan Total Intravenous Anesthesia (TIVA) Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021) Table 106. Lunan Total Intravenous Anesthesia (TIVA) Product Table 107. Lunan Recent Developments/Updates Table 108. Production Base and Market Concentration Rate of Raw Material Table 109. Key Suppliers of Raw Materials Table 110. Total Intravenous Anesthesia (TIVA) Distributors List Table 111. Total Intravenous Anesthesia (TIVA) Customers List Table 112. Total Intravenous Anesthesia (TIVA) Market Trends Table 113. Total Intravenous Anesthesia (TIVA) Growth Drivers Table 114. Total Intravenous Anesthesia (TIVA) Market Challenges Table 115. Total Intravenous Anesthesia (TIVA) Market Restraints Table 116. Global Total Intravenous Anesthesia (TIVA) Sales Forecast by Type (2022-2027) & (K Units) Table 117. Global Total Intravenous Anesthesia (TIVA) Sales Market Share Forecast by Type (2022-2027) Table 118. Global Total Intravenous Anesthesia (TIVA) Revenue Forecast by Type (2022-2027) & (US$ Million) Table 119. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share Forecast by Type (2022-2027) Table 120. Global Total Intravenous Anesthesia (TIVA) Sales Forecast by Application (2022-2027) & (K Units) Table 121. Global Total Intravenous Anesthesia (TIVA) Sales Market Share Forecast by Application (2022-2027) Table 122. Global Total Intravenous Anesthesia (TIVA) Revenue Forecast by Application (2022-2027) & (US$ Million) Table 123. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share Forecast by Application (2022-2027) Table 124. Global Total Intravenous Anesthesia (TIVA) Sales Forecast by Region (2022-2027) & (K Units) Table 125. Global Total Intravenous Anesthesia (TIVA) Sales Market Share Forecast by Region (2022-2027) Table 126. Global Total Intravenous Anesthesia (TIVA) Revenue Forecast by Region (2022-2027) & (US$ Million) Table 127. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share Forecast by Region (2022-2027) Table 128. Research Programs/Design for This Report Table 129. Key Data Information from Secondary Sources Table 130. Key Data Information from Primary Sources List of Figures Figure 1. Product Picture of Total Intravenous Anesthesia (TIVA) Figure 2. Global Total Intravenous Anesthesia (TIVA) Market Share by Type in 2020 & 2027 Figure 3. Propofol Product Picture Figure 4. Etomidate Product Picture Figure 5. Midazolam Product Picture Figure 6. Barbiturates Product Picture Figure 7. Others Product Picture Figure 8. Global Total Intravenous Anesthesia (TIVA) Market Share by Application in 2020 & 2027 Figure 9. Predominantly Emergency Figure 10. Orthopedic Figure 11. Cosmetic Surgeries Figure 12. Others Figure 13. Global Total Intravenous Anesthesia (TIVA) Revenue, (US$ Million), 2016 VS 2021 VS 2027 Figure 14. Global Total Intravenous Anesthesia (TIVA) Market Size 2016-2027 (US$ Million) Figure 15. Global Total Intravenous Anesthesia (TIVA) Sales 2016-2027 (K Units) Figure 16. Global Total Intravenous Anesthesia (TIVA) Market Size Market Share by Region: 2016 VS 20210 VS 2027 Figure 17. Total Intravenous Anesthesia (TIVA) Sales Share by Manufacturers in 2020 Figure 18. Global Total Intravenous Anesthesia (TIVA) Revenue Share by Manufacturers in 2020 Figure 19. The Global 5 and 10 Largest Total Intravenous Anesthesia (TIVA) Players: Market Share by Revenue in 2020 Figure 20. Total Intravenous Anesthesia (TIVA) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021 Figure 21. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region (2016-2021) Figure 22. Global Total Intravenous Anesthesia (TIVA) Sales Market Share by Region in 2020 Figure 23. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region (2016-2021) Figure 24. Global Total Intravenous Anesthesia (TIVA) Revenue Market Share by Region in 2020 Figure 25. U.S. Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 26. Canada Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 27. Germany Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 28. France Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 29. U.K. Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 30. Italy Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 31. Russia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 32. China Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 33. Japan Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 34. South Korea Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 35. India Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 36. Australia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 37. Taiwan Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 38. Indonesia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 39. Thailand Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 40. Malaysia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 41. Philippines Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 42. Vietnam Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 43. Mexico Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 44. Brazil Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 45. Argentina Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 46. Turkey Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 47. Saudi Arabia Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 48. U.A.E Total Intravenous Anesthesia (TIVA) Revenue Growth Rate (2016-2021) (US$ Million) Figure 49. Sales Market Share of Total Intravenous Anesthesia (TIVA) by Type (2016-2021) Figure 50. Sales Market Share of Total Intravenous Anesthesia (TIVA) by Application (2016-2021) Figure 51. Sales Market Share of Total Intravenous Anesthesia (TIVA) by Application in 2020 Figure 52. Revenue Share of Total Intravenous Anesthesia (TIVA) by Application (2016-2021) Figure 53. Revenue Share of Total Intravenous Anesthesia (TIVA) by Application in 2020 Figure 54. Manufacturing Cost Structure of Total Intravenous Anesthesia (TIVA) Figure 55. Manufacturing Process Analysis of Total Intravenous Anesthesia (TIVA) Figure 56. Total Intravenous Anesthesia (TIVA) Industrial Chain Analysis Figure 57. Channels of Distribution Figure 58. Distributors Profiles Figure 59. Bottom-up and Top-down Approaches for This Report Figure 60. Data Triangulation Figure 61. Key Executives Interviewed

B. Braun Medical Astrazeneca Fresenius-Kabi AbbVie Baxter Healthcare Maruishi Piramal Hikma Pharmaceuticals Mylan Nhwa Hengrui Lunan